OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BRAF somatic mutation contributes to intrinsic epileptogenicity in pediatric brain tumors
Hyun Yong Koh, Se Hoon Kim, Jaeson Jang, et al.
Nature Medicine (2018) Vol. 24, Iss. 11, pp. 1662-1668
Closed Access | Times Cited: 120

Showing 1-25 of 120 citing articles:

Low-grade developmental and epilepsy associated brain tumors: a critical update 2020
Rutger J. Slegers, Ingmar Blümcke
Acta Neuropathologica Communications (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 157

Contribution of Somatic Ras/Raf/Mitogen-Activated Protein Kinase Variants in the Hippocampus in Drug-Resistant Mesial Temporal Lobe Epilepsy
Sattar Khoshkhoo, Yilan Wang, Yasmine Chahine, et al.
JAMA Neurology (2023) Vol. 80, Iss. 6, pp. 578-578
Open Access | Times Cited: 54

Multi‐omics technologies and molecular biomarkers in brain tumor‐related epilepsy
Yaoqiang Du, Rusong Li, Danqing Fu, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 4
Open Access | Times Cited: 18

Precise detection of low-level somatic mutation in resected epilepsy brain tissue
Nam Suk Sim, Ara Ko, Woo Kyeong Kim, et al.
Acta Neuropathologica (2019) Vol. 138, Iss. 6, pp. 901-912
Closed Access | Times Cited: 126

New insights into a spectrum of developmental malformations related tomTORdysregulations: challenges and perspectives
Angelika Mühlebner, Anika Bongaarts, Harvey B. Sarnat, et al.
Journal of Anatomy (2019) Vol. 235, Iss. 3, pp. 521-542
Open Access | Times Cited: 80

Oncogenic BRAF Alterations and Their Role in Brain Tumors
Felix Behling, Jens Schittenhelm
Cancers (2019) Vol. 11, Iss. 6, pp. 794-794
Open Access | Times Cited: 79

Neocortical development and epilepsy: insights from focal cortical dysplasia and brain tumours
Ingmar Blümcke, Silvia Budday, Annapurna Poduri, et al.
The Lancet Neurology (2021) Vol. 20, Iss. 11, pp. 943-955
Closed Access | Times Cited: 74

Autophagy as a Potential Therapy for Malignant Glioma
Ángel Escamilla-Ramírez, Rosa Angélica Castillo‐Rodríguez, Sergio Zavala-Vega, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 7, pp. 156-156
Open Access | Times Cited: 71

Genetic mosaicism in the human brain: from lineage tracing to neuropsychiatric disorders
Sara Bizzotto, Christopher A. Walsh
Nature reviews. Neuroscience (2022) Vol. 23, Iss. 5, pp. 275-286
Closed Access | Times Cited: 56

The genomic landscape across 474 surgically accessible epileptogenic human brain lesions
Javier A. López-Rivera, Costin Leu, Marie Macnee, et al.
Brain (2022) Vol. 146, Iss. 4, pp. 1342-1356
Open Access | Times Cited: 49

Detection of brain somatic variation in epilepsy‐associated developmental lesions
Tracy A. Bedrosian, Katherine E. Miller, Olivia Grischow, et al.
Epilepsia (2022) Vol. 63, Iss. 8, pp. 1981-1997
Open Access | Times Cited: 40

Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current management
Edward K. Avila, Steven Tobochnik, Sara K. Inati, et al.
Neuro-Oncology (2023) Vol. 26, Iss. 1, pp. 7-24
Open Access | Times Cited: 38

Focal epilepsies: Update on diagnosis and classification
Fábio A. Nascimento, Daniel Friedman, Jurriaan M. Peters, et al.
Epileptic Disorders (2023) Vol. 25, Iss. 1, pp. 1-17
Open Access | Times Cited: 29

Epilepsy and brain tumors: Two sides of the same coin
Eleonora Aronica, Emilio Ciusani, Antonietta Coppola, et al.
Journal of the Neurological Sciences (2023) Vol. 446, pp. 120584-120584
Open Access | Times Cited: 23

A microglia clonal inflammatory disorder in Alzheimer’s disease
Rocío Vicario, Stamatina Fragkogianni, Leslie Weber, et al.
eLife (2025) Vol. 13
Open Access | Times Cited: 1

Neurodevelopmental Aspects of RASopathies
Ye Eun Kim, Seung Tae Baek
Molecules and Cells (2019) Vol. 42, Iss. 6, pp. 441-447
Open Access | Times Cited: 58

Detection of Brain Somatic Mutations in Cerebrospinal Fluid from Refractory Epilepsy Patients
Seyeon Kim, Sara Baldassari, Nam Suk Sim, et al.
Annals of Neurology (2021) Vol. 89, Iss. 6, pp. 1248-1252
Closed Access | Times Cited: 46

Brain Somatic Mutation in Aging and Alzheimer's Disease
Michael B. Miller, Hannah C. Reed, Christopher A. Walsh
Annual Review of Genomics and Human Genetics (2021) Vol. 22, Iss. 1, pp. 239-256
Open Access | Times Cited: 46

The complexities underlying epilepsy in people with glioblastoma
Elisaveta Sokolov, Jörg Dietrich, Andrew J. Cole
The Lancet Neurology (2023) Vol. 22, Iss. 6, pp. 505-516
Closed Access | Times Cited: 18

Non–Cell Autonomous Epileptogenesis in Focal Cortical Dysplasia
Hyun Yong Koh, Jaeson Jang, Sang Hyeon Ju, et al.
Annals of Neurology (2021) Vol. 90, Iss. 2, pp. 285-299
Closed Access | Times Cited: 37

Genomics in the presurgical epilepsy evaluation
Patrick B. Moloney, Patricia Dugan, Peter Widdess‐Walsh, et al.
Epilepsy Research (2022) Vol. 184, pp. 106951-106951
Closed Access | Times Cited: 19

Low-grade epilepsy-associated neuroepithelial tumors: Tumor spectrum and diagnosis based on genetic alterations
Mingguo Xie, Xiongfei Wang, Zejun Duan, et al.
Frontiers in Neuroscience (2023) Vol. 16
Open Access | Times Cited: 12

Glioma genetic profiles associated with electrophysiologic hyperexcitability
Steven Tobochnik, Maria Kristina Dorotan, Hia S. Ghosh, et al.
Neuro-Oncology (2023) Vol. 26, Iss. 2, pp. 323-334
Open Access | Times Cited: 12

RAS pathway: The new frontier of brain mosaicism in epilepsy
Sahibjot Sran, Tracy A. Bedrosian
Neurobiology of Disease (2023) Vol. 180, pp. 106074-106074
Open Access | Times Cited: 11

Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes
Lucas Hoffmann, Roland Coras, Katja Kobow, et al.
Acta Neuropathologica (2023) Vol. 145, Iss. 6, pp. 815-827
Open Access | Times Cited: 11

Page 1 - Next Page

Scroll to top